Trials / Completed
CompletedNCT04375241
Detection of Asymptomatic Atrial Fibrillation in Persons of 65 Year of Age or Older
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,168 (actual)
- Sponsor
- Diagram B.V. · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Accepted
Summary
Atrial fibrillation (AF) is the most common cardiac arrhythmia. Although the condition itself is not life-threatening, the complications result in increased morbidity and mortality. AF is often asymptomatic and a considerable number of people suffering from AF are not aware of their condition. Unfortunately, a cerebral infarction is often the first clinical manifestation. The idea to screen subjects opportunistically for Asymptomatic Atrial Fibrillation (AAF) was infeasible until recently. However, with a recently-developed smartphone connected Mobile ECG Device (MED), this seems to be feasible after all. The main objectives are: * To examine the feasibility of screening subjects of ≥65 years old for AAF. * To validate the smartphone connected MED as an AAF screening instrument for application in transmural care in the Netherlands.
Detailed description
Study design: Prospective validation study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Subjects with asymptomatic atrial fibrillation will be screened by using a Mobile ECG Device | Subjects with asymptomatic atrial fibrillation will be screened by using a Mobile ECG Device |
Timeline
- Start date
- 2018-07-02
- Primary completion
- 2021-04-30
- Completion
- 2021-04-30
- First posted
- 2020-05-05
- Last updated
- 2022-07-12
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT04375241. Inclusion in this directory is not an endorsement.